Fig. 3. Effects of glibenclamide (5 µmol l1), a
KATP channel blocker, and L-NAME (50 µmol
l1), an inhibitor of nitric oxide synthase (NOS), on the
percentage change in action potential duration at 90% repolarization
(APD90) induced by hypoxia in goldfish ventricle (N=4).
Hypoxia-induced APD90 shortening was eliminated by simultaneous
exposure to either glibenclamide or L-NAME. Values are mean change
± 1 S.E.M.